Daniel Przybylski

5PUBLICATIONS
2CO-AUTHORS
Haematological tumoursGene and molecular therapyRegenerative medicine (incl. stem cells)Molecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 19, 2026
Infectious complications associated with tocilizumab following chimeric antigen receptor T-cell therapy.

|Apr 04, 2022
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.

Keng Hee Peh, Daniel J Przybylski, Michael J Fallon

|Jan 27, 2021
Extemporaneous compounding and administration of tretinoin slurry for acute promyelocytic leukemia.

Daniel J Przybylski, Jason R Jared, Michael J Fallon

|Jan 07, 2021
Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities?

Daniel J Przybylski, Jason J Bergsbaken, Jennifer K Piccolo

|Jan 16, 2020
Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.

Daniel J Przybylski, Elizabeth N Dow-Hillgartner, Michael P Reed

Pageof 1

Frequent Collaborators

1 joint publications

Keng Hee Peh

1 joint publications

Virginia Bland